Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Brainsway Ltd ADR (BWAY)

Brainsway Ltd ADR (BWAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 101,157
  • Shares Outstanding, K 16,665
  • Annual Sales, $ 31,790 K
  • Annual Income, $ -4,200 K
  • 60-Month Beta 1.23
  • Price/Sales 3.16
  • Price/Cash Flow N/A
  • Price/Book 2.38
Trade BWAY with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.00
  • Number of Estimates 3
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year -0.10
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.33 +13.88%
on 05/29/24
7.30 -16.85%
on 06/05/24
+0.74 (+13.88%)
since 05/28/24
3-Month
4.61 +31.67%
on 04/18/24
7.30 -16.85%
on 06/05/24
+0.78 (+14.74%)
since 03/28/24
52-Week
2.01 +201.99%
on 07/06/23
7.61 -20.29%
on 01/08/24
+3.77 (+163.91%)
since 06/28/23

Most Recent Stories

More News
3 Growth Stocks Under $10 With Breakout Potential

Discover three under-the-radar biotech and medtech stocks that analysts believe could soar in 2024, each with unique growth drivers and significant upside potential.

MNMD : 7.21 (-0.55%)
LFWD : 4.01 (+1.26%)
BWAY : 6.07 (+0.83%)
BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 14% Year-over-Year in Q2 2022 Conference call to be held today, August 10, 2022, at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Aug. ...

BWAY : 6.07 (+0.83%)
BrainsWay to Report Second Quarter Financial Results on August 10, 2022

BURLINGTON, Mass. and JERUSALEM, July 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...

BWAY : 6.07 (+0.83%)
H.C. Wainwright Thinks Brainsway’s Stock is Going to Recover

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Brainsway (BWAY – Research Report) today and set a price target of $15.00. The company's shares closed last Friday at $4.90, close to...

BWAY : 6.07 (+0.83%)
BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression

The Company’s Groundbreaking Deep TMS™ Treatment is Included in Israel’s Health Basket of Essential Medical Services...

BWAY : 6.07 (+0.83%)
BrainsWay to Present at the H.C. Wainwright 1st Annual Mental Health Conference

BURLINGTON, Mass. and JERUSALEM, June 22, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...

BWAY : 6.07 (+0.83%)
BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights

Revenue Growth of 30% Year-over-Year in Q1 2022 Conference call to be held today, May 11, 2022, at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, May 11,...

BWAY : 6.07 (+0.83%)
BrainsWay Launches #DontMissAnotherMoment Social Media Campaign to Promote Mental Health Awareness Month

BrainsWay will donate $5 per share, $2 per comment, and $1 per like to support the work of Mental Health America...

BWAY : 6.07 (+0.83%)
BrainsWay to Report First Quarter Financial Results on May 11, 2022

BURLINGTON, Mass. and JERUSALEM, April 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global...

BWAY : 6.07 (+0.83%)
Megastar HR Launches Stellar HR Services with Grand Opening

New Utah-based HR firm aims to reverse declining nationwide employee engagement rates SANDY, UT / ACCESSWIRE / April 25, 2022 / According to a 2021 Gallup survey, only 36% of employees are engaged at work....

BWAY : 6.07 (+0.83%)
DYNT : 0.2650 (-20.97%)

Business Summary

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder....

See More

Key Turning Points

3rd Resistance Point 6.55
2nd Resistance Point 6.39
1st Resistance Point 6.23
Last Price 6.07
1st Support Level 5.91
2nd Support Level 5.75
3rd Support Level 5.59

See More

52-Week High 7.61
Last Price 6.07
Fibonacci 61.8% 5.47
Fibonacci 50% 4.81
Fibonacci 38.2% 4.15
52-Week Low 2.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar